Get Started

AGPU

NASD Axe Compute Inc.
Oct 23, 2026 · 7:54 PM ET LAST TRADE Market Closed

$7.77 ↑ +0.00 (+0.00%) Trading Up from the previous close of $7.77, $0.14 below the day’s high of $7.91

YTD change
+8.67%
vs 20-day SMA
-26.04%
vs 200-day SMA
+18.25%

Price ranges

Previous day
$7.59 $8.61
open $8.55 close $7.77
-$0.78 (-9.12%)
Today
$7.37 $7.91
open $7.77 now $7.77
+$0.00 (+0.00%)
Past week
$7.59 $9.03
from $8.41 now $7.77
-$0.64 (-7.61%)
Past month
$7.50 $13.49
from $11.35 now $7.77
-$3.58 (-31.54%)
This year
$1.03 $13.49
from $7.15 now $7.77
+$0.62 (+8.67%)

Price & Performance

+0.67 (+9.44%) / 6M

$4.02$7.23$10.44$13.65Apr 23Jul 24Oct 22

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 42.4% away from all-time highs of $13.49
  • AGPU is up 9% since the beginning of the year
  • AGPU is up 31% over the past 12 months
  • AGPU is down 32% over the past 1 month
  • 3% of all AGPU investors are betting against AGPU

AGPU reads not so good: price sits above one of the two key moving averages, the 12-month move is +30.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.87
Earnings momentum -200.0% Quarterly EPS growth
Quarterly change -200.0%

Valuation

P/E ratio 0.62
Enterprise value $132.7M
Beta 6.37

Balance sheet & scale

IncomeN/A
Revenue$3.3M
Cash$21.9M
Debt$1.7K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Miscellaneous Manufacturing
Market cap $195.0M

Axe Compute, Inc. engages in the provision of graphics processing unit compute capacity for artificial intelligence and other complex computing workloads. It operates through the following segments: Compute Services and Treasury Management segment, and Drug Discovery Services segment. The Compute Services and Treasury Management segment provides services that include access to GPU compute capacity and manage the ATH Treasury Strategy. The Drug Discovery Services segment provides services that include the application of AI, creation of specific 3D culture models used in drug development. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Pittsburgh, PA.

Competitor comparison

TickerCompany PriceChange
JNJ.CAT JOHNSON & JOHNSON CDR CAD HEDGED $34.11 +3.80%
BDX Becton, Dickinson and Company $200.42 +3.13%
MDLN Medline, Inc. Class A $34.88 -1.22%
DXCM DexCom, Inc. $78.32 -2.42%
WST West Pharmaceutical Services, Inc. $394.03 +0.14%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.